ArticleDiabetes care2024

Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.

Leah E Cahill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.